Jason Lewis plays for Memorial Sloan Kettering Cancer Center

PwP: How did you get involved with PWP?

JL: I got introduced to Stacey and her husband Alex through mutual contacts a few years back. We had a lot of mutual friends, professional contacts, and I thought Stacey’s passion for this project was inspiring. I knew I wanted to become involved with the team.

PwP: Why did you pick MSK as your charity?

JL: Unfortunately, we lost my father to a rare blood disorder that was a precursor to Leukemia a few years back. Through his treatment, my family and I learned a lot about cancer research and how important it is to dedicate resources to finding better treatments. In recent years, I have gotten close to MSK and have participated in their Cycle for Survival events. That event is a lot of fun and raises so much awareness and money for fighting rare cancers. I have also gotten to know personally many of the doctors and employees of MSK and become familiar with the groundbreaking work they are doing. It is a remarkable institution and needs all the help it can to stay on the forefront of innovative cancer research and technology.

PwP: What have you liked about PWP?

JL: It combines so many of the things I find interesting—investing, competition, and philanthropy.  I also like to see many contacts I have within my industry are involved including many of the well-known investment managers. Currently in 10th place myself, I am watching the Leader Board everyday right now. Nothing would make me happier than to be able to deliver a nice check to MSK later this year for picking the best performing portfolio of stocks. There’s a lot of people I would love to brag about this to.

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) is the world’s oldest and largest private cancer center, home to more than 13,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. As an independent institution, we combine 130 years of research and clinical leadership with the freedom to provide highly individualized, exceptional care to each patient. Today, we are one of 41 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment.

The close collaboration between our physician and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at MSK has an impact on cancer treatment and biomedical research around the world.

MSK is defined by more than just exceptional clinicians, investigators, and employees. Every patient who seeks our help, every family member who needs our support, every committed donor who advances our mission—all are an integral part of our community. It is now easier than ever to get involved and raise funds for groundbreaking cancer research and patient care. For more information, please visit www.giving.mskcc.org.

Saundra Marcel